Cheviot Value Management, LLC Ligand Pharmaceuticals Inc Transaction History
Cheviot Value Management, LLC
- $820 Million
- Q1 2025
A detailed history of Cheviot Value Management, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Cheviot Value Management, LLC holds 200 shares of LGND stock, worth $30,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$30,012% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
285Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$431 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$314 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$154 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$136 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$112 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.53B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...